Precigen Free Cash Flow Per Share vs Free Cash Flow Yield Analysis

PGEN Stock

USD 0.93 0.02 2.20%

Precigen financial indicator trend analysis is much more than just breaking down Precigen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precigen is a good investment. Please check the relationship between Precigen Free Cash Flow Per Share and its Free Cash Flow Yield accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Free Cash Flow Per Share vs Free Cash Flow Yield

Free Cash Flow Per Share vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precigen Free Cash Flow Per Share account and Free Cash Flow Yield. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Precigen's Free Cash Flow Per Share and Free Cash Flow Yield is 0.94. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Precigen, assuming nothing else is changed. The correlation between historical values of Precigen's Free Cash Flow Per Share and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Precigen are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Free Cash Flow Per Share i.e., Precigen's Free Cash Flow Per Share and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Precigen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precigen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.At this time, Precigen's Discontinued Operations is very stable compared to the past year. As of the 1st of December 2024, Sales General And Administrative To Revenue is likely to grow to 1.09, while Selling General Administrative is likely to drop about 38.4 M.

	2021	2022	2023	2024 (projected)
Interest Expense	18.9M	6.8M	468K	444.6K
Depreciation And Amortization	8.1M	7.2M	6.7M	6.3M

Interest Expense Depreciation And Amortization

Precigen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Inventory
Total Assets		0.06	0.32	0.65	0.9	0.67	0.9	-0.3	0.21	0.7	0.84	0.98	0.22	0.81	0.93	0.09	0.62	0.1	-0.12	0.14	0.26	0.86	0.89	-0.13	0.9	0.87
Short Long Term Debt Total	0.06		0.68	0.4	-0.04	0.54	-0.23	0.91	-0.57	0.4	0.33	-0.08	-0.89	0.15	0.09	0.44	0.01	0.14	0.37	0.61	0.24	0.18	0.36	0.36	-0.1	0.19
Other Current Liab	0.32	0.68		0.82	0.28	0.52	0.12	0.54	-0.51	0.4	0.42	0.19	-0.58	0.23	0.45	0.5	0.03	-0.08	0.17	0.6	0.13	0.4	0.54	0.61	0.28	0.28
Total Current Liabilities	0.65	0.4	0.82		0.54	0.64	0.54	0.2	-0.21	0.62	0.54	0.57	-0.28	0.39	0.76	0.37	0.22	0.04	0.17	0.41	0.28	0.57	0.72	0.6	0.59	0.48
Total Stockholder Equity	0.9	-0.04	0.28	0.54		0.48	0.75	-0.34	0.0	0.55	0.7	0.86	0.23	0.84	0.83	0.32	0.73	-0.33	-0.01	0.35	-0.19	0.81	0.84	-0.08	0.81	0.83
Property Plant And Equipment Net	0.67	0.54	0.52	0.64	0.48		0.52	0.29	-0.1	0.9	0.67	0.64	-0.21	0.43	0.63	0.18	0.18	0.3	-0.07	0.27	0.44	0.66	0.61	0.04	0.58	0.56
Current Deferred Revenue	0.9	-0.23	0.12	0.54	0.75	0.52		-0.5	0.35	0.56	0.6	0.94	0.46	0.61	0.83	-0.06	0.49	0.25	-0.21	-0.12	0.37	0.66	0.65	-0.25	0.92	0.64
Net Debt	-0.3	0.91	0.54	0.2	-0.34	0.29	-0.5		-0.66	0.16	-0.08	-0.42	-0.94	-0.17	-0.25	0.45	-0.19	0.05	0.45	0.56	0.1	-0.13	0.02	0.43	-0.43	-0.13
Retained Earnings	0.21	-0.57	-0.51	-0.21	0.0	-0.1	0.35	-0.66		-0.03	0.13	0.31	0.69	0.03	0.14	-0.9	0.0	0.52	-0.57	-0.9	0.45	0.19	-0.05	-0.42	0.14	0.23
Accounts Payable	0.7	0.4	0.4	0.62	0.55	0.9	0.56	0.16	-0.03		0.63	0.66	-0.08	0.54	0.7	0.17	0.37	0.21	-0.04	0.26	0.35	0.61	0.67	0.04	0.61	0.55
Cash	0.84	0.33	0.42	0.54	0.7	0.67	0.6	-0.08	0.13	0.63		0.77	-0.01	0.77	0.8	0.05	0.45	0.22	-0.13	0.21	0.35	0.74	0.85	-0.12	0.75	0.77
Non Current Assets Total	0.98	-0.08	0.19	0.57	0.86	0.64	0.94	-0.42	0.31	0.66	0.77		0.36	0.71	0.91	-0.01	0.52	0.16	-0.18	0.01	0.29	0.81	0.77	-0.22	0.93	0.81
Non Currrent Assets Other	0.22	-0.89	-0.58	-0.28	0.23	-0.21	0.46	-0.94	0.69	-0.08	-0.01	0.36		0.09	0.18	-0.53	0.12	0.05	-0.66	-0.65	-0.02	0.14	-0.12	-0.57	0.36	0.06
Cash And Short Term Investments	0.81	0.15	0.23	0.39	0.84	0.43	0.61	-0.17	0.03	0.54	0.77	0.71	0.09		0.68	0.18	0.91	-0.12	-0.05	0.29	-0.02	0.74	0.91	-0.21	0.67	0.79
Net Receivables	0.93	0.09	0.45	0.76	0.83	0.63	0.83	-0.25	0.14	0.7	0.8	0.91	0.18	0.68		0.14	0.46	0.08	-0.11	0.2	0.27	0.77	0.84	0.07	0.88	0.76
Common Stock Shares Outstanding	0.09	0.44	0.5	0.37	0.32	0.18	-0.06	0.45	-0.9	0.17	0.05	-0.01	-0.53	0.18	0.14		0.21	-0.6	0.56	0.96	-0.48	0.06	0.28	0.38	0.11	0.02
Short Term Investments	0.62	0.01	0.03	0.22	0.73	0.18	0.49	-0.19	0.0	0.37	0.45	0.52	0.12	0.91	0.46	0.21		-0.27	0.04	0.26	-0.2	0.57	0.75	-0.2	0.44	0.65
Non Current Liabilities Total	0.1	0.14	-0.08	0.04	-0.33	0.3	0.25	0.05	0.52	0.21	0.22	0.16	0.05	-0.12	0.08	-0.6	-0.27		-0.27	-0.56	0.97	0.0	-0.02	-0.25	0.1	0.0
Other Current Assets	-0.12	0.37	0.17	0.17	-0.01	-0.07	-0.21	0.45	-0.57	-0.04	-0.13	-0.18	-0.66	-0.05	-0.11	0.56	0.04	-0.27		0.56	-0.22	-0.35	0.04	0.5	-0.14	-0.13
Other Stockholder Equity	0.14	0.61	0.6	0.41	0.35	0.27	-0.12	0.56	-0.9	0.26	0.21	0.01	-0.65	0.29	0.2	0.96	0.26	-0.56	0.56		-0.43	0.14	0.4	0.42	0.1	0.14
Total Liab	0.26	0.24	0.13	0.28	-0.19	0.44	0.37	0.1	0.45	0.35	0.35	0.29	-0.02	-0.02	0.27	-0.48	-0.2	0.97	-0.22	-0.43		0.14	0.15	-0.09	0.24	0.11
Property Plant And Equipment Gross	0.86	0.18	0.4	0.57	0.81	0.66	0.66	-0.13	0.19	0.61	0.74	0.81	0.14	0.74	0.77	0.06	0.57	0.0	-0.35	0.14	0.14		0.83	-0.11	0.64	0.93
Total Current Assets	0.89	0.36	0.54	0.72	0.84	0.61	0.65	0.02	-0.05	0.67	0.85	0.77	-0.12	0.91	0.84	0.28	0.75	-0.02	0.04	0.4	0.15	0.83		0.1	0.71	0.85
Short Term Debt	-0.13	0.36	0.61	0.6	-0.08	0.04	-0.25	0.43	-0.42	0.04	-0.12	-0.22	-0.57	-0.21	0.07	0.38	-0.2	-0.25	0.5	0.42	-0.09	-0.11	0.1		-0.19	-0.14
Intangible Assets	0.9	-0.1	0.28	0.59	0.81	0.58	0.92	-0.43	0.14	0.61	0.75	0.93	0.36	0.67	0.88	0.11	0.44	0.1	-0.14	0.1	0.24	0.64	0.71	-0.19		0.61
Inventory	0.87	0.19	0.28	0.48	0.83	0.56	0.64	-0.13	0.23	0.55	0.77	0.81	0.06	0.79	0.76	0.02	0.65	0.0	-0.13	0.14	0.11	0.93	0.85	-0.14	0.61

Click cells to compare fundamentals

Precigen Account Relationship Matchups

Precigen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	455.8M	314.6M	359.9M	216.0M	151.0M	143.5M
Short Long Term Debt Total	247.9M	182.3M	194.2M	51.4M	7.1M	6.7M
Other Current Liab	73.5M	31.7M	28.6M	30.1M	19.5M	30.4M
Total Current Liabilities	122.9M	42.1M	34.6M	78.6M	23.0M	21.8M
Total Stockholder Equity	71.7M	67.2M	107.3M	126.3M	118.5M	112.6M
Property Plant And Equipment Net	86.2M	44.3M	45.2M	15.4M	14.2M	13.5M
Current Deferred Revenue	5.7M	2.8M	4.4M	25K	509K	483.6K
Net Debt	182.2M	130.5M	151.3M	46.6M	(481K)	(457.0K)
Retained Earnings	(1.7B)	(1.8B)	(1.9B)	(1.9B)	(2.0B)	(1.9B)
Accounts Payable	5.9M	4.6M	3.1M	4.1M	1.7M	1.6M
Cash	65.8M	51.8M	42.9M	4.9M	7.6M	7.2M
Non Current Assets Total	221.1M	165.6M	203.2M	97.8M	82.3M	78.2M
Non Currrent Assets Other	(13.9M)	(8.6M)	(14.8M)	(8.5M)	497K	521.9K
Cash And Short Term Investments	75.1M	100.1M	115.2M	56.0M	62.9M	93.0M
Net Receivables	26.2M	20.4M	2.0M	13.8M	1.6M	1.5M
Common Stock Shares Outstanding	154.1M	167.1M	197.8M	200.4M	244.5M	134.9M
Short Term Investments	9.3M	48.3M	72.2M	51.1M	55.3M	53.0M
Liabilities And Stockholders Equity	455.8M	314.6M	359.9M	216.0M	151.0M	143.5M
Non Current Liabilities Total	261.1M	205.3M	217.9M	11.1M	9.6M	9.1M
Other Current Assets	6.4M	17.0M	45.7M	48.1M	4.3M	4.1M
Other Stockholder Equity	1.8B	1.9B	2.0B	2.0B	2.1B	1.3B
Total Liab	384.1M	247.4M	252.5M	89.7M	32.5M	30.9M
Total Current Assets	234.6M	148.9M	156.6M	118.2M	68.8M	65.3M
Accumulated Other Comprehensive Income	(27.5M)	4.0M	203K	(3.5M)	(1.9M)	(2.0M)
Short Term Debt	37.8M	3.0M	1.4M	44.4M	1.2M	1.1M
Intangible Assets	68.3M	65.4M	54.1M	44.5M	40.7M	78.7M
Inventory	21.4M	16.1M	11.4M	13.3M	287K	0.95
Good Will	63.8M	54.4M	54.1M	36.9M	26.6M	25.3M
Net Tangible Assets	(60.4M)	(52.6M)	(915K)	126.3M	113.6M	81.8M
Long Term Debt	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Retained Earnings Total Equity	(1.7B)	(1.8B)	(1.9B)	(1.9B)	(1.7B)	(1.8B)
Long Term Debt Total	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Capital Surpluse	1.8B	1.9B	2.0B	2.0B	2.3B	1.7B
Deferred Long Term Liab	7.2M	2.8M	2.9M	2.5M	2.3M	2.2M
Non Current Liabilities Other	57.4M	72.0M	30.9M	32.6M	37.5M	27.7M
Property Plant Equipment	61.0M	34.9M	45.2M	7.3M	6.6M	6.3M

Pair Trading with Precigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Precigen Stock

0.63

ELAN

Elanco Animal Health

Pair Corr

Moving against Precigen Stock

0.62	EWTX	Edgewise Therapeutics	Pair Corr
0.6	BHC	Bausch Health Companies	Pair Corr
0.54	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.53	GANX	Gain Therapeutics	Pair Corr
0.47	GILD	Gilead Sciences	Pair Corr

The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.

The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:

How To Invest In Precigen

Details

Is Precigen Stock a good investment?

Details

What is Precigen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.54)

Revenue Per Share

0.018

Quarterly Revenue Growth

(0.59)

Return On Assets

(0.42)

Return On Equity

(1.29)

The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Precigen Free Cash Flow Per Share vs Free Cash Flow Yield Analysis

Free Cash Flow Per Share vs Free Cash Flow Yield

Free Cash Flow Per Share vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Free Cash Flow Yield

Precigen fundamental ratios Correlations

Precigen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Precigen fundamental ratios Accounts

Pair Trading with Precigen

Moving together with Precigen Stock

Moving against Precigen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.98	Total Assets
Total Liab	+ 0.97	Non Current Liabilities Total
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.94	Current Deferred Revenue
Net Receivables	+ 0.93	Total Assets
Intangible Assets	+ 0.93	Non Current Assets Total

Non Currrent Assets Other	- 0.94	Net Debt
Other Stockholder Equity	- 0.9	Retained Earnings
Common Stock Shares Outstanding	- 0.9	Retained Earnings
Non Currrent Assets Other	- 0.89	Short Long Term Debt Total
Other Current Assets	- 0.66	Non Currrent Assets Other
Retained Earnings	- 0.66	Net Debt